During the last two decades, major progress has been made in the technology of flow cytometry and in the availability of a large series of monoclonal antibodies against surface membrane and intracellular antigens. Flow cytometric immunophenotyping has become a diagnostic tool for the analysis of normal and malignant leukocytes and it has proven to be a reliable approach for the investigation of minimal residual disease (MRD) in leukemia patients during and after treatment. 
Introduction
Differentiation of B cells from early committed progenitors to mature B-lymphocytes is a multistep maturation process that can be monitored by the coordinated acquisition and loss of leukocyte differentiation antigens. Several hypothetical models of B cell differentiation have been proposed in which the consecutive sequence of antigen expression is described, thus enabling the definition of different stages of B cell maturation. [1] [2] [3] Initially, most concepts of human early B cell development were derived from studies on precursor-B-acute lymphoblastic leukemia (precursor-B-ALL). [4] [5] [6] More recently, studies have focused on the investigation of normal bone marrow (BM) [7] [8] [9] thanks to technical improvements and refinements of multiparameter flow cytometry, which allows the analysis of large numbers of normal B cells, even when present at very low frequencies. 10 In addition, extensive panels of monoclonal antibodies against B cell-associated leukocyte differentiation antigens have been generated, whole blood/BM staining methods have been developed, new fluorochromes with high sensitivity emission signals have been discovered 11, 12 and methods for flow cytometric intracellular stainings have been improved substantially. 13 These combined technical advances have contributed to a better insight in the discrete maturation stages of normal B cell development. Several controversies concerning the consecutive expression of antigens throughout B cell differentiation have been clarified, and minor B cell subpopulations have been identified in normal BM, such as those coexpressing CD34 and CD20 or CD34 and CD22. [14] [15] [16] Nevertheless, some controversies remain: classical models 3, 5, 6 have been challenged by the possible existence of parallel pathways of B cell development; 17 furthermore, differences between fetal and postnatal BM B cell precursors have been reported 5, 17, 18 indicating also that postnatal age-related differences which mainly involve the relative distribution of the different BM B cell subsets, exist. 9, 19, 20 However, in these studies procedures have been used in which pre-enrichment steps for mononuclear cells are included. This limits the potential value of the enumeration of the different BM cell subsets due to the existence of important levels of uncontrolled loss of cells of interest. 21 Accordingly, to the best of our knowledge, no systematic study of B cell differentiation at different ages has been performed in a large series of healthy individuals using a whole bone marrow sample preparation technique.
In the present study, we performed a standardized flow cytometric analysis at six different sites of a total of 38 normal human BM samples from healthy individuals whose age ranged from 2 to 75 years. Our major goal was to investigate the BM B cell compartment in order to generate a frame of reference for the identification of leukemia-associated pheno-types in precursor B-ALL cases. The definition of the normal patterns of B cell differentiation was based on: (1) the objective identification of clearly defined subsets of B cells corresponding to discrete stages of B cell maturation; (2) the relative distribution of each of these subsets from the total BM cellularity; and (3) the definition of flow cytometry dot-plot templates corresponding to the normal B cell differentiation pathways. 
Materials and methods

Specimen collection
Sample preparation
BM samples were collected in heparin or EDTA anticoagulant, immediately diluted 1/1 (vol/vol) in phosphate-buffered saline (PBS) and maintained at room temperature until processed. In all cases, sample preparation and flow cytometric data acquisition were performed within the first 24 h after collection. For the immunophenotypic studies a stain and then lyse technique was used. Briefly, 2 × 10 6 nucleated cells were incubated for 10 min with saturating amounts of fluorochrome-conjugated mouse anti-human monoclonal antibodies at room temperature in the dark, followed by incubation for 10 min with 2 ml of FACS lysing solution (Becton Dickinson (BD), San Jose, CA, USA) diluted 1/10 (vol/vol) in distilled water. After centrifugation (5 min, 500 g), cells were resuspended in 1 ml PBS with 0.2% BSA or subjected to intracellular staining for terminal deoxynucleotidyl transferase (TdT) according to a previously described procedure.
13,22
Immunophenotypic analysis
For standardization purposes, all groups used the same set of monoclonal antibodies conjugated with fluorescein isothiocyanate (FITC), phycoerythrin (PE) and either peridin chlorophyll protein (PerCP) or the PE/cyanine 5 (PE/Cy5) fluorochrome tandem. The antibodies' clones were carefully selected on the basis of their reactivity patterns and the absence of background staining. Their source and specificity were as follows: CD10-FITC (W8E7), CD19-FITC (leu12), CD20-PE (leu16), CD22-PE (leu14), CD34-FITC (HPCA2), CD34-PE (HPCA2), CD38-PE (leu17) and CD45-PerCP (Hle1) were purchased from BD, CD10-PE (J5) and CD19-PE/Cy5 (J4.119) were from Coulter/Immunotech (Miami, FL, USA), CD19-PE/Cy5 (SJ25-C1) was from CALTAG Laboratories (San Francisco, CA, USA) and TdT-FITC (HT6) from DAKO (Glostrup, Denmark).
Subsequently, the triple fluorochrome-conjugated monoclonal antibody combinations were extensively tested in the six participating laboratories according to predefined guidelines. Based on the combined results, the following five triple immunofluorescence stainings were established: CD10-FITC/ CD20-PE/CD19-PE-Cy5, CD34-FITC/CD38-PE/CD19-PE-Cy5, CD34-FITC/CD22-PE/CD19-PE-Cy5, CD19-FITC/CD34-PE/ CD45-PerCP, and TdT-FITC/CD10-PE/CD19-PE-Cy5. Irrelevant monoclonal antibody reagents of the same isotypes as in the triple combinations, conjugated with the same fluorochromes, were used as negative controls.
For standardized calibration of the flow cytometer, normal peripheral blood lymphocytes were stained with CD3-FITC (Leu-4, BD), CD4-PE (Leu-3, BD), and CD8-PE/Cy5 (3B5; CALTAG Laboratories) and were measured in parallel with each BM sample. Data acquisition was performed in all centers with FACS can flow cytometers (BD), using either the Lysis II (BD) or CellQuest (BD) software programs. In all cases, a two-step acquisition procedure was used. Accordingly, 15 000 events from total BM were acquired first; in the second step, a B cell gate was established on the basis of CD19 expression and low right angle light scatter (SSC), as previously described 23 and a minimum of 100 000 events were analyzed for each monoclonal antibody combination. This gate was used to acquire data for the specific characterization of the different B cell subpopulations. Additional live gates were defined based on CD34 or TdT expression for better discrimination between the most immature subsets and for identification of potential CD19 negative B cell precursors. The percentage of each subset was calculated from the total number of nucleated BM cells as previously described. 24 The analyses were performed on either Hewlett-Packard or MacIntosh computers using the Paint-A-Gate software (BD).
Standardization of the procedures and quality control
All procedures used for the immunophenotypic analysis of the normal BM B cell compartment were standardized among the six participating centers prior to the study. This included both experimental work and regular meetings of scientists and technicians from all participating centers. For that purpose the same reagents and techniques were used throughout the study at each individual site. As mentioned above decisions on reagent selection were performed at different levels including selection of monoclonal antibody clones, fluorochrome conjugates and triple-staining combinations. The combinations which were agreed upon were those providing the most powerful discrimination between the subsets under study. In 421 a further step, the procedures used for instrument set-up and calibration were also comparatively evaluated and a common and standardized method was selected. The scatter characteristics and the autofluorescence levels of normal peripheral blood (PB) lymphocytes were used as the reference, based on which instrument settings were established. A specific meeting was devoted to educate the personnel of each participating laboratory in this regard. As described above a common twostep acquisition procedure was used in all centers and the same applied to data analysis with Paint-A-Gate software.
Quality control of the procedures was performed both prior to and during the study. For that purpose analysis of a normal PB sample stained for the CD3-FITC (leu4)/CD4-PE (leu3)/CD8-PE-Cy5 (3B5) triple combination was performed on a daily basis. Additionally, data files were exchanged and analyzed at different sites and a cross-comparison of the results obtained, was performed.
Statistical analysis
All results are expressed as mean values with one standard deviation, as well as range. Statistical significance of the differences observed was determined with the paired Student's ttest (P Ͻ 0.05).
Results
Identification of early CD19 − hemopoietic cell progenitors expressing B cell-associated antigens in normal BM and phenotypic characterization of sequential stages of B cell development
In order to identify the potential earliest stages of B cell differentiation in normal BM, we used two triple combinations CD34/CD22/CD19 and TdT/CD10/CD19 with specific gating on CD34
+ and TdT + cells. Two immature subpopulations were identified by the coexpression of CD34 Figure 2 (green dots). This subpopulation covers 0.44 ± 0.65% (range 0.01% to 4.06%) of the total BM nucleated cells.
An intermediate B cell maturation stage was characterized by coexpression of CD19, CD10, CD22, and CD45 (subpopulation 2, Table 1 ). A clear distinction from subpopulation 1 was observed, based on the loss of TdT and CD34 and decreased CD10 expression (Figure 2, red dots) ; the CD45 and CD20 expression is more intense in this subpopulation, as compared to more immature CD34 + B cell precursors. Interestingly, we did not find changes in the expression of CD22 and CD38, which remained dim and bright, respectively. This subset of B cells represented 3.75 ± 5.75% (range 0.05% to 29.59%) of all BM nucleated cells.
A more mature CD19 + B cell subpopulation was phenotypically defined by the absence of CD10 and a decreased CD38 expression, as well as by a brighter expression of CD22 and CD45 (subpopulation 3, Table 1 ). This subpopulation represented 2.58 ± 1.43% (range 2.32% to 3.10%) of all BM nucleated cells (Figure 2, blue dots) .
According to these results, Figure 3 summarizes the sequence of antigen expression by the different B cell subpopulations that were identified in the BM samples. It is noteworthy that a high degree of concordance was observed between the relative proportions of each of the three CD19 + B cell subsets identified by the different MAb combinations. An exception to this observation was the relative distribution of subpopulations 2 and 3, when the CD19/CD34/CD45 triple combination was used (Table 1) .
Looking for the relative size of subpopulations 1 to 3 in different individuals, a high degree of variability was observed in the proportion of subpopulation 2, which appeared to be age-related (see below). Variability in the relative size of the other subpopulations was less pronounced ( Table 1) .
Distribution of early CD19-hemopoietic progenitors expressing B cell-associated antigens and CD19 + B cell subpopulations in normal BM according to age
The relative proportions of all precursor B cell subpopulations were analyzed according to the donor's age, which ranged from 2 to 75 years. Regarding the most immature CD19 − cells, a higher proportion of cells from population A was observed in childhood BM, as compared to adult BM (mean value of 0.15 ± 0.11% and 0.07 ± 0.02% of the childhood and adult BM, respectively; P = 0.03). In contrast, when the TdT/CD10/CD19 combination was used, no significant difference in the proportion of subpopulation B was found between children and adults (0.05 ± 0.07% and 0.04 ± 0.03%, respectively; P = 0.65).
With regard to the relative size of the CD19 + B cell subpopulations, the data showed significant changes in subpopulations 1 and 2, but not in subpopulation 3 (Table 1) . With respect to the proportion of subpopulation 1 and 2, two groups could be defined: children (р15 years; n = 18) and adults (Ͼ15 years; n = 20). A clear decrease in the relative frequency of B cells belonging to these two subpopulations was observed in older individuals, while the relative frequency of the more mature B cells (population 3) is stable throughout age.
Considering the relative size of the CD19 + subpopulations according to the total BM nucleated cells, it was observed that the size of subpopulation 1 was larger in children than in adults (ranges for the different monoclonal antibody combinations from 0.66 ± 0.84% to 0.77 ± 0.70% in children and from 0.12 ± 0.12% to 0.18 ± 0.14% in adults, P р 0.03) ( Table  1) . Subpopulation 2 was found to be the largest B cell subpopulation in children's BM and to be significantly larger than in adults (range for the different monoclonal antibody combinations of 5.17 ± 6.12% to 7.15 ± 7.43% in children and 0.75 ± 0.51% to 0.86 ± 0.60% in adults, P р 0.01) ( Table 1) . When assessed as a fraction of the total BM cellularity, the number of cells belonging to subpopulation 3 was similar in children and adults, although a trend to lower values could be observed in BM samples from older donors ( Table 1 ). 
Reproducibility of results
Since the results presented in this paper were pooled from those obtained for different individual BM samples in six different institutions, we wanted to confirm that the variations found with age were real and not dependent on a differential distribution of individuals/samples or on results among the centers. Therefore, we performed a comparison of the flow cytometric data files obtained in the six participating institutions and we found a high degree of reproducibility among the centers as regards the dot plot templates obtained and the phenotypic characteristics of the different subsets analyzed; this also applied to the relative distribution of each subset whenever the comparison between centers was performed in an age-matched way.
Figure 2
Flow cytometric analysis of subpopulations 1, 2 and 3 within the CD19 + gate. Subpopulation 1 (green dots), is CD10 bright and CD20
+ (e). Subpopulation 2 (red dots) is defined by the acquisition of CD20 (a), the loss of CD34 and TdT (c to f) and the decrease of CD10 expression which occur simultaneously with the increase in intensity of CD19. Dot plot 'b' illustrates the distinction between subpopulations 1 and 2 when using the CD10/CD19 combination. Subpopulation 3 (blue dots) is characterized by the expression of CD20 
Discussion
The sequential expression of specific antigens during maturation of normal precursor-B cells in BM has been extensively studied during the past decades, leading to several models of B cell lineage maturation. Although there is a consensus for most antigens, frequently discordant findings are reported.
14,25-29 These discrepancies might be due to differences in methodological approaches, the origin of hematopoietic cell samples (fetal liver, fetal BM, or post-natal BM), and in the age of BM donors. Furthermore, it is not yet clear whether the sequential expression of functional antigens during the early phases of B cell differentiation follows a rigid sequence or, alternatively, may vary both in normal and in malignant B cell development. 30 The study presented here was performed in six different laboratories. Therefore, careful attention was paid to the standardization and quality control of the various technical According to our data, the sequence of antigen expression during B cell maturation somehow differs from the classical models of B cell development proposed by Loken et al. 1 We observed that the CD22 antigen is already expressed on the membrane of the most immature B cells, preceding CD10 and CD19 expression. This finding contrasts with earlier reports, where the expression of surface CD22 was considered to be a relatively late phenomenon in B cell maturation, 1 but is in agreement with more recent studies with sensitive multiparameter flow cytometric analyses. 14, 31, 32 Our results show the existence of immature CD19
− BM precursors that coexpress the CD22 B cell associated antigen together with CD34; these cells correspond to 0.15% of the total BM cellularity in children and 0.07% in adults. Regarding the potential B cell commitment of these progenitor cells, it should be noted that although CD22 is a pan-B antigen which is usually negative in T, NK and granulomonocytic cells it has been reported as positive in certain subsets of normal myeloid cells such as mast cells 33 and dendritic cells. 34 However, through the use of additional multiple stainings we were not able to confirm the existence of cells coexpressing CD22 and CD34 in the absence of CD19 that displayed clear reactivity for other dendritic cell or mast cell associated markers. 33, 35 Using the TdT/CD10/CD19 triple combination, we identified a very small subpopulation showing reactivity for TdT and CD10 in the absence of CD19 (subpopulation B). This is in line with the earlier observation that expression of CD10 may precede that of CD19 in early B cell differentiation 17, 30, 36, 37 and that B cells may originate together with T, NK and dendritic cells from a CD34
− precursor cell. 38 Therefore, this subpopulation might represent the earliest B cell precursors. Nevertheless,it must be noted that the commitment to the B cell lineage of these CD10
− cells is not universally accepted. In a recent study it has been shown that CD34
− BM precursor cells give rise to macrophage colonies. 39 In the present study we could identify this minor subpopulation in all samples but, in con-trast to the other maturation stages, we did not observe a significant variation of its relative size with the age of the donors. We also observed that these cells express CD10 at lower density than the more mature B cell precursors. Further multiple stainings demonstrated that these cells are CD22 − (data not 2 and 3, respectively) . Each of the antibody combinations was, by itself, sufficient to identify the three different stages (Figure 4) . Interestingly, slight variations were observed in the relative distribution of populations 2 and 3 with the CD19/CD34/CD45 combination as compared with the other multiple stainings. This probably reflects a lower discriminative power of CD45 to clearly separate between populations 2 and 3. In this sense, it should be noted that selection of the fluorochrome conjugates was essential to obtain the highest discriminative power between the different BM cell subsets for each combination.
As previously shown, childhood BM is enriched for immature B cells. 5, 9 Here we observe that the more immature CD19 + B cell subpopulations 1 and 2 make up to 70% of all CD19 + B cells in BM of children under 15 years, a pattern that contrasts with that of adults, where subpopulation 3 predominates, representing over 70% of the total CD19 + B cells. The transition between these two phenotypic patterns of precursor-B cell subpopulations occurs in a rather abrupt way around the age of 15 years, mainly due to the relative decrease of subpopulations 1 and 2 beyond this age. This decrease in subpopulations 1 and 2 beyond the age of 15 is responsible for the overall decrease of the pool of CD19 + BM cells in adults also found by Caldwell et al. 9 In this sense it is not reasonable to think that these differences could be related to the potential contamination of the BM specimens with PB since children usually show higher numbers of PB mature B cells as compared to adults. In spite of this, in specific cases significant levels of contamination of BM samples with PB may exist.
The flow cytometric multiparameter analysis presented here can be used for studying normal B cell maturation but it is conceivable that this approach may facilitate the diagnostic and follow-up studies of patients with precursor-B-ALL. For instance, it might be important to investigate whether the agerelated switch in immunophenotype reported here also occurs in children and adults with precursor-B-ALL. Furthermore, the precise identification of normal precursor-B cell subpopulations in BM also permits the definition of 'templates' in the multidimensional dot-plot representations of each monoclonal antibody combination ( Figure 5 ). These dot plot 'templates' could not only be considered as a reference frame for pinpointing of aberrant phenotypes falling into the so-called 'empty-spaces', but also for the detection of an abnormal distribution of the populations found in the normal differentiation pathways. This approach will most probably be of utmost importance for improving the standardization of strategies and simplifying the methodology aimed at the detection of MRD in precursor-B-ALL. 27, 28, [40] [41] [42] [43] 
